Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

epidermal growth factor receptor

  • You have access
    Lewis y Expressed in Oral Squamous Cell Carcinoma Attenuates Malignant Properties via Down-regulation of EGF Signaling
    HIROSHI HOTTA, KAZUNORI HAMAMURA, HIDENOBU SHIBUYA, YUHSUKE OHMI, KEIKO FURUKAWA and KOICHI FURUKAWA
    Anticancer Research April 2021, 41 (4) 1821-1830; DOI: https://doi.org/10.21873/anticanres.14948
  • You have access
    Epidermal Growth Factor Receptor and its Oncogenic EGFRvIII Variant in Benign and Malignant Brain Tumors
    MICHAL KIELBUS, RADOSLAW ROLA, BOZENA JAROSZ, WITOLD JELENIEWICZ, MAREK CYBULSKI, AGNIESZKA STENZEL-BEMBENEK, ARKADIUSZ PODKOWINSKI, JOLANTA SMOK-KALWAT, KRZYSZTOF POLBERG, TOMASZ TROJANOWSKI, DAWID STEFANIUK and ANDRZEJ STEPULAK
    Anticancer Research February 2021, 41 (2) 983-991; DOI: https://doi.org/10.21873/anticanres.14852
  • You have access
    Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice
    YUTAKA YAMADA, TOMOHIRO TAMURA, YUSUKE YAMAMOTO, HIDEO ICHIMURA, KENJI HAYASHIHARA, TAKEFUMI SAITO, HIDEYASU YAMADA, TAKEO ENDO, RYOTA NAKAMURA, YOSHIHISA INAGE, HIROAKI SATOH, KESATO IGUCHI, KAZUTO SAITO, MASAHARU INAGAKI, NORIHIRO KIKUCHI, KOICHI KURISHIMA, HIROICHI ISHIKAWA, MITSUAKI SAKAI, KOICHI KAMIYAMA, TOSHIHIRO SHIOZAWA, NOBUYUKI HIZAWA, IKUO SEKINE, YUKIO SATO, YASUNORI FUNAYAMA, KUNIHIKO MIYAZAKI, TAKAHIDE KODAMA, SHIGEN HAYASHI, AKIHIRO NOMURA, HIROYUKI NAKAMURA, KINYA FURUKAWA, TAKAAKI YAMASHITA, HATSUMI OKUBO, HISASHI SUZUKI, MORIYUKI KIYOSHIMA and TAKAYUKI KABURAGI
    Anticancer Research October 2020, 40 (10) 5757-5764; DOI: https://doi.org/10.21873/anticanres.14592
  • You have access
    Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer
    ANA LAURA ORTEGA-GRANADOS, ÁNGEL ARTAL-CORTES, DAVID AGUIAR-BUJANDA, JUANA ORAMAS, JOSÉ LUIS FÍRVIDA, JAVIER DE CASTRO, JUANA CAMPILLO FUENTES, ROCÍO GORDO, RAQUEL GALÁN, JOSÉ TRIGO and on behalf of the ASPET Study Investigators
    Anticancer Research March 2019, 39 (3) 1317-1328; DOI: https://doi.org/10.21873/anticanres.13244
  • You have access
    Radiolabeling, Characteristics and NanoSPECT/CT Imaging of 188Re-cetuximab in NCI-H292 Human Lung Cancer Xenografts
    WAN-I KUO, KAI-HUNG CHENG, YA-JEN CHANG, TSUNG-TSE WU, WEI-CHUAN HSU, LIANG-CHENG CHEN and CHIH-HSIEN CHANG
    Anticancer Research January 2019, 39 (1) 183-190; DOI: https://doi.org/10.21873/anticanres.13096
  • You have access
    A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
    MATTHEW R. KEARNEY, EMERSON Y. CHEN, GINA M. VACCARO, JOHN STROTHER, ANDREA BURT, KENDRA TODD, JEFF DONOVAN, KERSTIN M. KAMPA-SCHITTENHELM and CHARLES D. LOPEZ
    Anticancer Research January 2019, 39 (1) 245-252; DOI: https://doi.org/10.21873/anticanres.13104
  • You have access
    Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring EGFR Mutation
    SHINKICHI TAKAMORI, GOUJI TOYOKAWA, MOTOTSUGU SHIMOKAWA, FUMIHIKO KINOSHITA, YUKA KOZUMA, TAICHI MATSUBARA, NAOKI HARATAKE, TAKAKI AKAMINE, NOBUTAKA MUKAE, FUMIHIKO HIRAI, TETSUZO TAGAWA, YOSHINAO ODA, TORU IWAKI, KOJI IIHARA, HIROSHI HONDA and YOSHIHIKO MAEHARA
    Anticancer Research June 2018, 38 (6) 3731-3734; DOI: https://doi.org/10.21873/anticanres.12653
  • You have access
    Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study
    AKIHIRO TAMIYA, MOTOHIRO TAMIYA, TAKASHI NISHIHARA, TAKAYUKI SHIROYAMA, KEIKO NAKAO, TAISUKE TSUJI, NAOKO TAKEUCHI, SHUN-ICHI ISA, NAOKI OMACHI, NORIO OKAMOTO, HIDEKAZU SUZUKI, KYOICHI OKISHIO, AYANO IWAZAKI, KIMIE IMAI, TOMONORI HIRASHIMA and SHINJI ATAGI
    Anticancer Research August 2017, 37 (8) 4177-4182;
  • You have access
    Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07
    DOLORES ISLA, ENRIQUETA FELIP, NURIA VIÑOLAS, MARIANO PROVENCIO, MARGARITA MAJEM, ANGEL ARTAL, ISABEL BOVER, PILAR LIANES, RAMÓN DE LAS PEÑAS, SILVIA CATOT, JAVIER DE CASTRO, ANA BLASCO, JOSEFA TERRASA, JOSÉ LUIS GONZALEZ-LARRIBA, OSCAR JUAN, MANUEL DÓMINE, REYES BERNABE and PILAR GARRIDO
    Anticancer Research December 2016, 36 (12) 6647-6653;
  • You have access
    Appetite Loss as an Adverse Effect During Treatment with EGFR-TKIs in Elderly Patients with Non-small Cell Lung Cancer
    MINEHIKO INOMATA, KAZUKI SHIMOKAWA, KOTARO TOKUI, CHIHIRO TAKA, SEISUKE OKAZAWA, KENTA KAMBARA, TORU YAMADA, TOSHIRO MIWA, RYUJI HAYASHI, TATSUHIKO KASHII, SHOKO MATSUI and KAZUYUKI TOBE
    Anticancer Research September 2016, 36 (9) 4951-4954;

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire